OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
3.925
+0.025 (0.64%)
Nov 21, 2024, 1:51 PM EST - Market open
OmniAb Employees
OmniAb had 106 employees as of December 31, 2023. The number of employees increased by 11 or 11.58% compared to the previous year.
Employees
106
Change (1Y)
11
Growth (1Y)
11.58%
Revenue / Employee
$192,538
Profits / Employee
-$594,509
Market Cap
474.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 106 | 11 | 11.58% |
| Dec 31, 2022 | 95 | 21 | 28.38% |
| Dec 31, 2021 | 74 | 4 | 5.71% |
| Dec 31, 2020 | 70 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Emergent BioSolutions | 1,600 |
| Health Catalyst | 1,300 |
| Pacific Biosciences of California | 796 |
| MeiraGTx Holdings | 425 |
| Xeris Biopharma Holdings | 377 |
| REGENXBIO | 344 |
| UroGen Pharma | 201 |
| Acelyrin | 135 |
OABI News
- 8 days ago - OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights - Business Wire
- 22 days ago - OmniAb to Participate in Two Investor Conferences in November - Business Wire
- 4 weeks ago - OmniAb to Report Third Quarter 2024 Financial Results on November 12 - Business Wire
- 3 months ago - OmniAb to Participate in Two Investor Conferences in September - Business Wire
- 3 months ago - OmniAb, Inc. (OABI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights - Business Wire
- 3 months ago - Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging - Seeking Alpha